Emron Is Closed

Since 1987 Emron has provided biopharmaceutical managed market and reimbursement & access teams with solution support toward gaining, maintaining and enhancing appropriate drug reimbursement access. Emron has many capabilities around drug launch support in pre, peri and post drug commercialization stages of access for managed care teams. We have experience with orphan, oncology, biosimilar, biotechnology and pharmaceutical drug classes. Emron assisted in the creation of AMCP in 1989 and remains an active member today. Emron has relationships with, and a deep database of, influential channel insight partners that can assist Emron build account management strategies & tactics. Emron is known for many pillar program publications such as the "Pharmacy Benefit Report" sponsored by Novartis for 20 years, the "Oncology Trend Report" sponsored by Genentech for 5 years, among other channel and disease state annual reports sponsored by various biopharmaceutical companies. Whether your need is content around; product, disease state {branded/non-branded}, channel customers or healthcare quality & policy issues we have capabilities aimed to provide you and your team value. Our website is: www.Emron.com Consider Emron first for your managed markets and reimbursement & access account management solutions.